The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,012
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Mash, D. C., Flynn, D. D., & Potter, L. T. (1985) · Science · doi:10.1126/science.3992249 · Cited by 698
Optic-Nerve Degeneration in Alzheimer's Disease
Hinton, D. R., Sadun, A. A., Blanks, J. C., & Miller, C. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150804 · Cited by 694
Sahakian, B., Jones, G., Levy, R., Gray, J., & Warburton, D. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.6.797 · Cited by 494
Self-citationDunnett, S. B. (1985) · Psychopharmacology · doi:10.1007/bf00432721 · Cited by 484
Sustained attention in human performance
Bellamy, L. J. (1985) · Applied Ergonomics · doi:10.1016/0003-6870(85)90149-8 · Cited by 469
Effects of scopolamine and nicotine on human rapid information processing performance
Wesnes, K., & Warburton, D. M. (1984) · Psychopharmacology · doi:10.1007/bf00427761 · Cited by 354
Self-citationIntravenous nicotine in Alzheimer's disease: a pilot study
Newhouse, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Cited by
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282
Coull, J. T. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00011-2 · Cited by 882
Bartus, R. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7397 · Cited by 829
Neuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 782
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Nicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 678
Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 666
Coull, J. T., Frith, C. D., Frackowiak, R. S. J., & Grasby, P. M. (1996) · Neuropsychologia · doi:10.1016/0028-3932(96)00029-2 · Cited by 566
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 416
Effects of nicotinic stimulation on cognitive performance
Newhouse, P. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 405
Nicotine and smoking: A review of effects on human performance.
Heishma, S. J., Taylor, R. C., & Henningfield, J. E. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.2.4.345 · Cited by 370
Acetylcholine, Aging, and Alzheimer's Disease
Muir, J. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00431-5 · Cited by 360
Practice parameter: Management of dementia (an evidence-based review)
Oken, B. S. (2001) · Neurology · doi:10.1212/wnl.57.12.2323 · Cited by 351
Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications
Nordberg, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01125-2 · Cited by 339
Cognitive Mechanisms of Nicotine on Visual Attention
Lawrence, N. S., Ross, T. J., & Stein, E. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)01004-8 · Cited by 322
Multiple neuronal networks mediate sustained attention
Lawrence, N. S., Ross, T. J., Hoffmann, R., Garavan, H., & Stein, E. A. (2003) · Journal of Cognitive Neuroscience · doi:10.1162/089892903770007416 · Cited by 310
Di Carlo, A., Baldereschi, M., Amaducci, L., Maggi, S., Grigoletto, F., Scarlato, G., Inzitari, D., & for the Italian Longitudinal Study on Aging Working Group (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04752.x · Cited by 300
Stimulant drugs and vigilance performance: a review
Koelega, H. S. (1993) · Psychopharmacology · doi:10.1007/bf02257400 · Cited by 285
Guan, Z., Zhang, X., Ravid, R., & Nordberg, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740237.x · Cited by 285
The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
Steckler, T., & Sahgal, A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00157-b · Cited by 281
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease
White, H. K., & Levin, E. D. (1999) · Psychopharmacology · doi:10.1007/s002130050931 · Cited by 273
Newhouse, P. A., Potter, A., & Levin, E. D. (1997) · Drugs & Aging · doi:10.2165/00002512-199711030-00005 · Cited by 267
Decker, M. W., Brioni, J. D., Bannon, A. W., & Arneric, S. P. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00488-e · Cited by 260
Court, J., Spurden, D., Lloyd, S., McKeith, I., Ballard, C., Cairns, N., Kerwin, R., Perry, R., & Perry, E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 254
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder
Biederman, J., Spencer, T., & Wilens, T. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003973 · Cited by 253
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240
Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1931 · Cited by 230
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Functional mitochondria are required for amyloid β‐mediated neurotoxicity
Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203
Witte, E. A., Davidson, M. C., & Marrocco, R. T. (1997) · Psychopharmacology · doi:10.1007/s002130050352 · Cited by 187
Local Infusion of Scopolamine Into Intraparietal Cortex Slows Covert Orienting in Rhesus Monkeys
Davidson, M. C., & Marrocco, R. T. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.3.1536 · Cited by 188
Dalley, J. W. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh052 · Cited by 191
Non?stimulant medications in the treatment of ADHD
Banaschewski, T., Roessner, V., Dittmann, R. W., Janardhanan Santosh, P., & Rothenberger, A. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1010-x · Cited by 183
Nicotinic receptors in human brain: topography and pathology
Court, J. A., Martin-Ruiz, C., Graham, A., & Perry, E. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00110-1 · Cited by 180
Biological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176
Raskind, M. A., Peskind, E. R., Truyen, L., Kershaw, P., & Damaraju, C. V. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.252 · Cited by 167
Wilens, T. E., & Decker, M. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.002 · Cited by 164
Potter, A., Corwin, J., Lang, J., Piasecki, M., Lenox, R., & Newhouse, P. A. (1999) · Psychopharmacology · doi:10.1007/s002130050897 · Cited by 163
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162
Caffeine attenuates scopolamine-induced memory impairment in humans
Reidel, W., Hogervorst, E., Leboux, R., Verhey, F., van Praag, H., & Jolles, J. (1995) · Psychopharmacology · doi:10.1007/bf02246090 · Cited by 152
Nicotinic treatment of Alzheimer’s disease
Newhouse, P. A., Potter, A., Kelton, M., & Corwin, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01069-6 · Cited by 146
McGaughy, J., Decker, M. W., & Sarter, M. (1999) · Psychopharmacology · doi:10.1007/s002130050991 · Cited by 128
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training
Gould, T. J., & Stephen Higgins, J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00057-1 · Cited by 123
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
Gatto, G. J., Bohme, G. A., Caldwell, W. S., Letchworth, S. R., Traina, V. M., Obinu, M. C., Laville, M., Reibaud, M., Pradier, L., Dunbar, G., et al. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00010.x · Cited by 111
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Decker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37015-6 · Cited by 88
Smoking, Death, and Alzheimer Disease: A Case of Competing Risks
Chang, C.-C. H., Zhao, Y., Lee, C.-W., & Ganguli, M. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182420b6e · Cited by 85
Leveraging the cortical cholinergic system to enhance attention
Demeter, E., & Sarter, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.060 · Cited by 75
Cholinergic modulation of response gain in the primary visual cortex of the macaque
Soma, S., Shimegi, S., Osaki, H., & Sato, H. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00330.2011 · Cited by 75
Warburton, D. M., Rusted, J. M., & Fowler, J. (1992) · Psychopharmacology · doi:10.1007/bf02247418 · Cited by 72
Self-citationScopolamine slows the orienting of attention in primates to cued visual targets
Davidson, M. C., Cutrell, E. B., & Marrocco, R. T. (1999) · Psychopharmacology · doi:10.1007/s002130050855 · Cited by 61
Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats
Melichercik, A. M., Elliott, K. S., Bianchi, C., Ernst, S. M., & Winters, B. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.008 · Cited by 54
Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29
Animal Paradigms to Assess Cognition with Translation to Humans
Wallace, T. L., Ballard, T. M., & Glavis-Bloom, C. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-16522-6_2 · Cited by 26
The functional therapeutic chemical classification system
Croset, S., Overington, J. P., & Rebholz-Schuhmann, D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt628 · Cited by 11
A unifying hypothesis of alzheimer’s disease: III—Risk factors
Heininger, K. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(200001)15:1<1::aid-hup153>3.0.co;2-1
Metadata
- Authors
- Jones, G. M. M., Sahakian, B. J., Levy, R., Warburton, D. M., & Gray, J. A.
- Venue
- Psychopharmacology
- Published
- 1992-09
- Volume
- 108
- Issue
- 4
- Pages
- 485-494
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2068987805
- Cited by
- 476
- References
- 39
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.